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This cross-sectional multi-centre study explored how family members and friends of illicit drug users perceived protective
and risk factors, treatment facilities and policies and laws regarding illicit drug use. Family members and friends of illicit
drug users were recruited in 10 urban health care outpatient units in 7 Latin American countries (Brazil, Colombia, Costa
Rica, Ecuador, Guatemala, Honduras and Mexico) to complete a questionnaire. The majority of the respondents chose
psycho-social factors over genetic or biological explanations as causes of drug problems. Respondents felt that families and
governments were responsible for preventing drug problems. Church/religious institutions were most often mentioned in the
context of accessible treatment. When asked about access to treatment facilities, the majority said that there were not
enough. Shame about drug use, cost, and limited treatment options were most often cited as barriers to treatment.
DESCRIPTORS: street drugs; substance-related disorders; risk factors; protection; family; friends; health services
accessibility; Latin America; multicenter study
EL USO DE DROGAS ILÍCITAS EN SIETE PAÍSES LATINOAMERICANOS:
UNA PERSPECTIVA CRÍTICA DE FAMILIARES Y PERSONAS CERCANAS
Este estudio transversal multicéntrico exploró como los familiares y personas cercanas de usuarios de drogas ilícitas perciben
los factores de protección y los de riesgo, las facilidades de tratamiento, las iniciativas de prevención y la legislación relativa
a las drogas ilícitas. Los familiares y personas cercanas de los usuarios de drogas ilícitas fueron reclutados en 10 unidades
urbanas de atención de salud en ambulatorios, en 7 países de América Latina (Brasil, Colombia, Costa Rica, Ecuador,
Guatemala, Honduras y México) para responder a una encuesta. Con respecto a las causas de los problemas de las drogas,
la mayoría de los encuestados destacó los factores psicosociales como siendo más importantes que los factores genéticos o
biológicos. Los encuestados consideraron que las familias y los gobiernos son quienes tienen más responsabilidad en la
prevención de los problemas de drogas. La iglesia y las instituciones religiosas fueron mencionadas con mayor frecuencia en
el contexto del acceso al tratamiento. Cuando se les preguntó sobre el acceso a las facilidades de tratamiento, la mayoría
manifestó que éstas no eran suficientes. Como barreras para el tratamiento, citaron entre las más frecuentes, la vergüenza
por el uso de las drogas, la falta de opciones para su tratamiento y el costo del mismo.
DESCRIPTORES: drogas ilícitas; trastornos relacionados con sustancias; factores de riesgo; protección; familia; amigos;
accesibilidad a los servicios de salud; América Latina; estudio multicéntrico
USO DE DROGAS ILÍCITAS EM SETE PAÍSES DA AMÉRICA LATINA:
PERSPECTIVAS CRÍTICAS DE FAMILIARES E PESSOAS PRÓXIMAS
Este estudo multicêntrico corte temporal explorou a perspectiva de familiares e pessoas próximas a usuários de drogas
ilícitas sobre fatores de risco e proteção, serviços de tratamento, políticas e leis relacionadas ao uso de drogas ilícitas. Os
familiares e pessoas próximas a usuários de drogas ilícitas foram recrutados em dez unidades de saúde, localizadas em
grandes centros urbanos de sete países da América Latina (Brasil, Colômbia, Costa Rica, Equador, Guatemala, Honduras e
México), para responderem um questionário. A maioria dos participantes escolheu fatores psicossociais e não fatores
genéticos ou biológicos para explicar a causa dos problemas do uso de drogas. Responderam que familiares e governantes
são os principais responsáveis pela prevenção dos problemas das drogas. As igrejas e outras instituições religiosas foram
mencionadas com frequência dentro do contexto de acesso ao tratamento. A maioria dos entrevistados apontou que o
acesso aos serviços que oferecem tratamentos aos usuários de drogas não é suficiente. Vergonha sobre o uso de drogas,
custo e opções insuficientes de tratamento foram citados com mais frequência como as principais barreiras para o tratamento.
DESCRITORES: drogas ilícitas; transtornos relacionados ao uso de substâncias; fatores de risco; proteção; família; amigos;
acesso aos serviços de saúde; América Latina; estudo multicêntrico
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INTRODUCTION
Problems stemming from illicit drug use are
a major concern for individual countries and
international organizations. These problems affect an
increasing proportion of the world population. The
World Health Organization (WHO) estimates 200,000
deaths from drug abuse in the year 2000,
corresponding to 0.4 per cent of all deaths worldwide(1).
In addressing these problems, it is important to
consider among others the following critical elements:
protective and risk factors, preventive initiatives,
treatment facilities and laws and policies.
Understanding the role of family members and friends
is essential to better face the challenges related to
illicit drug use, especially for effective preventive and
treatment responses(2-3).
Protective and Risk Factors
Protective factors, as pointed out are those
attributes/ characteristics of individuals or their
environment/context which inhibit, reduce or lessen
the probability of drug use and/or abuse(4). Key
protective factors for drug use are easy temperament,
social and emotional competence, religious
involvement, family attachment, low parental conflicts,
effective parent–adolescent communication, well-
managed community environment, and marriage in
early adulthood(5). On the other hand, risk factors are
as those characteristics, variables, or hazards that
make it more likely for an individual to develop a
health problem(6). Drug use is also associated with
economic and psycho-social factors such as poverty,
social inequity, high unemployment rates, difficulties
in family adjustment, unhealthy occupational
environment, low education level and
homelessness(7).
Drug use usually begins in adolescence(7),
when individuals may not have a clear idea of its risks.
Initially, use is limited to one substance and to specific
situations. Over time, drug use tends to increase(8).
Protective and risk factors have dimensions that
influence the design of preventive programs and policies:
community, school, family and the individual(8-9).
Preventive Initiatives
Prevention comprises processes to promote
well-being, growth and optimal development at
individual, family and community levels. It is aimed
at foreseeing problems, enabling early intervention,
avoiding drug use, strengthening protective factors,
and decreasing risk factors. Prevention is based on
the premise that empirically verifiable precursors
(protective and risk factors) predict the likelihood of
undesired health outcomes including drug use.
Undesired health outcomes can be prevented by
reducing or eliminating risk factors and enhancing
protective factors in individuals and in their
environment(9). Prevention can be broadly categorized
as risk reduction, harm reduction, demand reduction
and health promotion. Individuals and communities
can be placed on a risk continuum varying from no
risk to high risk(9-11). Effective prevention requires a
broader health promotion approach and has to be
linked to other drug control responses in order to
achieve long term benefits(12).
Treatment Facilities
Research findings indicate that maintaining
therapeutic contact for extended periods of time, with
individuals with alcohol and other drug problems, may
promote better long-term outcomes than limited
treatment contact, ‘treatment as usual’(13). Most of the
treatment facilities in Latin America follow
standardized treatment principles recommended by
more developed countries. The Latin American
Federation of Therapeutic Communities(14) developed
a model that meets the illicit drug users’ needs based
on the principle that the cause of the drug use problem
is not the drug, but the person as the main interpreter
of his or her rehabilitation.
Laws and Policies
Facing the justice system for drug use can
expose users to severe criminal penalties(15). As a
result, safeguards are necessary to protect the rights
of individuals in compulsory treatment or prison(16).
Furthermore, a balance must be found between state
powers to detain persons involuntarily for public health
and safety reasons and the personal rights of
individuals while detained for treatment or
rehabilitation(17).
Since the 1980s, significant new legislation
has been enacted in Latin America for the purposes
of protecting the population from drug use, of
stimulating preventive initiatives and of establishing
treatment programs. The Organization of American
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States (OAS), through the Inter-American Drug Abuse
Control Commission (CICAD), plays an important role
in the Americas, providing guidelines for anti-drugs
cooperation in the hemisphere.
The perspectives of policy makers, scientists,
health care providers and drug users are not sufficient
to tackle the challenges presented by illicit drug
problems. The views of drug users’ family and friends
- who live and share the experience – are critical for
the successes and failures of preventive initiatives,
treatment facilities and laws and policies. Their lived
and shared experience is critical for understanding the
problem and for designing, following-up and evaluating
services provided to the community in Latin America.
The research question of this study is: “How
do illicit drug users’ family and friends describe
protective and risk factors, preventive initiatives,
treatment facilities, and policies and laws respecting
illicit drug use?” Its purpose is to gather information
and describe illicit drug users’ family and friends’
perspectives in seven Latin American countries about
(i) what protective and risk factors contribute to the
development of drug related problems; (ii) the
availability and accessibility of preventive initiatives
for illicit drug use, (iii) the availability and adequacy
of existing treatment, rehabilitation, and social
reintegration programs, and (iv) existing policies and
laws pertaining to illicit drug use.
METHODS
This study was approved by the Centre for
Addiction and Mental Health (CAMH) / University of
Toronto (UT) Research Ethics Board, the Heath
Canada Research Ethics Board and by the institutional
research ethics boards of each investigator’s home
university. This is a multi-centre cross-sectional study
utilizing both quantitative and qualitative methods. The
research was carried out in 10 health care outpatient
units in eight urban centers of seven Latin American
countries. These urban centers were Ribeirão Preto
and Rio de Janeiro (Brasil), Bogota (Colombia), San
Jose (Costa Rica), Guayaquil (Ecuador), Guatemala
City (Guatemala), San Pedro del Sula (Honduras) and
Queretaro (Mexico).
Participants
The sample was composed of a subset of the
population. The research involved men and women
over 18 years of age, self-defined and perceived by
the researcher as cognitively fit and self-identified as
being personally affected by, and caring for, a family
member or friend who is (or was) an illicit drug user.
Excluded were people under 18 years of age, people
not cognitively fit, former illicit drug users or people
using illicit drug(s). Participants were recruited in ten
health care outpatient units through the posting of
informational fliers, distribution of brochures, and
snowball technique. The snowball technique was
chosen as a recruitment strategy because of the
sensitive nature of illicit drug use.
A sample size of 100 participants per each
health care outpatient unit was chosen based on
available resources per site and on a number that
would ensure sufficient variation in participant
characteristics and experiences. One hundred people
were selected at each unit - one unit in each urban
area except Rio de Janeiro, where 3 units contributed
to the sample. The total sample (N) was 1008.
Data Collection and Analysis
Quantitative data was collected by closed-
ended survey questionnaires answered by all
participants including information on: demographic
information and data on participants’ knowledge about
risk and protective factors, prevention initiatives,
treatment facilities, policies and laws. The survey
included also questions regarding stigma experienced
by the family and friends of illicit drug users.
The qualitative section collected information
in more detail on these topics that could not easily be
obtained through closed questions. A sub-set (n=100)
of the total study sample also participated in open-
ended, semi-structured interviews in each site.
Quantitative and qualitative data was collected by the
researchers, trained students, or community-based
research assistants. The research teams in all seven
countries followed procedures based on the study
manual to ensure inter-rater reliability. Confidential
interviews were scheduled according to the
convenience and confidentiality assurance of both
participant and interviewer.
To standardize data capture, an EpiData®
template was developed at CAMH and distributed to
each site for data entry. Upon completion of data entry,
each site transferred their data file to the CICAD/
OAS office, which then merged the data into a single
file and distributed it to all sites. Data were managed
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and statistically analyzed using the Statistical Package
for the Social Sciences (SPSS® Version for Windows).
Analyses were comprised of basic descriptive statistics,
including frequency distributions of the main study
variables.
The overview of research findings featured
in this issue focus primarily on presenting results of
initial quantitative analysis. Articles presenting the
qualitative data are planned for future publications.
RESULTS
While it was challenging to select topics from
a rather extensive questionnaire, several themes are
highlighted: Demographic characteristics of
respondents, Demographic characteristics and illicit
drugs of illicit drug users, Perceptions of drug users,
Protective and risk factors, Preventive initiatives,
Treatment facilities, Laws and policies and
Respondents feeling stigmatized. For each theme the
results for the merged data (N=1008) are noted. The
results are a combination of percentages and average
scores on a four point (1 to four) scale.
Demographic characteristics of respondents
The majority of the respondents were female
(66.7%). Overall, 27.1% indicated that they had completed
high school, and 31.5% had additional education. Most
were employed (44%) or self-employed (17.6). Two-thirds
(66.2%) owned their own home. 46.8 of the respondents
declared a total family gross income per month below
1,000 US dollars. Most were living with someone, either
their spouse (47.6%), children (47.4%), or with a family
member other than their spouse or children (34.4%).
75.1% had access to public health care; 31% had access
to private health care.
Demographic characteristics and illicit drugs of illicit
drug users
Illicit drug users’ relationships to respondents
were friend (31.8%), other relative (19%), sibling
(17.4%), child (15.3%), and other (12%). In contrast
to the sex of the respondents - most were female - the
majority of the illicit drug users were male (81.2%).
Their average age was 27.9 years and they lived with
other relatives (57.7%), with a spouse or partner
(22.8%), or alone (15.1%). Respondents identified the
illicit drugs used by their family member or friend as
cannabis/marijuana (74.7%), crack/cocaine (62.5%),
hallucinogens (14%), glue or other inhalants (13%),
heroin/opium (7.5%), benzodiazepines (5.5%), and
prescription opioids (2.6%).
Perceptions of drug users
Respondents were asked to assess
statements about drug users. A higher score indicates
more support for the statement. Average scores
ranked from 2.03 for people thinking less of a person
who has been hospitalized for drug problems, to
higher scores for the following: people believing
anyone with drug problems cannot be trusted (3.06),
people looking down on someone who has been
hospitalized for drug problems (3.03), and employers
not willing to hire someone who has had drug problems
(3.09).
Protective and risk factors
The majority of the respondents (from 83.5%
to 87.7%) indicate support for the protective factors
studied: being able to express feelings, emotions and
thoughts, participation in sports, cultural and learning
activities, spiritual or religious involvement, having
strong morals, principles or character, having a healthy
lifestyle, having short-term and long-term goals and
having an optimistic and positive view on life.
Respondents identified many risk factors (Table 1),
with curiosity to try new substances and feelings and
having poor self concept/self esteem being most often
mentioned.
esugurdticillirofsrotcafksiR %
sgnileefdnasecnatsbuswenyrtotytisoiruC 2.29
meetsefles/tpecnocflesroopgnivaH 2.58
noisserpedfosgnileef/ssenilenoL 4.48
erusaelp/nufevahotgnihsiW 5.38
slliksgnipoclaicosetauqedanignivaH 0.67
noisneherpmoc/sgurdfoegdelwonkfokcaL 6.57
occabotdnalohoclagnisuecneirepxesuoiverpgnivaH 1.57
srossertsefilynamgnivaH 9.27
91-61neewtebegA 2.96
)ainerhpozihcs,noisserped.g.e(redrosidlatnemagnivaH 7.36
dnepsotyenomgnivaH 9.06
)scitsiretcarahcciteneg/lacigoloibcificeps(ytidereH 6.24
melborplacisyhpagnivaH 5.83
Table 1 - Frequency of risk factors identified by illicit
drug users’ family and friends
n= 1008
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Preventive initiatives
Respondents were asked who is responsible
for preventing illicit drug problems. A higher score
indicates perception of more responsibility. There were
higher average scores in the merged data for families
(3.43), then governments (3.07), schools (2.77),
church/religious institutions (2.19) and private
initiatives/companies (2.17).
Treatment facilities
Respondents were asked about the
availability of various treatment services (Table 2).
Church groups and health care services were the most
mentioned.
ecivreStnemtaerTfoepyT %
spuorghcruhC 8.25
latipsohlareneG 2.74
scinilcerachtlaeH 5.64
sresuremrofhtiwspuorgtroppuS 2.83
secivreserachtlaehlatneM 6.82
sretneceracyaD 3.62
latipsohcirtaihcysP 1.62
secivresgnilesnuocylimaF 0.62
spuorgtroppusylimaF 0.42
seitinummoccitueparehT 2.22
sredivorptnemtaertdetalugernU 2.31
latipsohdezilaicepS 7.21
Table 2 - Availability of treatment services according
to illicit drug users’ family and friends
n= 1008
Overall, 73.4% of the respondents indicated
that there were not enough facilities in their
community for illicit drug use problems, and 72.6%
indicated that it was not easy to get to the facilities.
Respondents were asked about barriers to treatment.
A higher score indicates greater perception of this as
a barrier. The rank order of responses was: Perceived
stigma about drug use (3.16), Cost (3.08), not enough
treatment options (2.98), not enough specific
medication (2.88), long waiting lists (2.84), lack of
specialized professionals (2.83), limited working /
opening hours (2.77), distance (2.73) and lack of
transportation (2.54).
Laws and policies
Respondents were asked about consequences
of national laws and policies regarding illicit drugs. A
higher score indicates greater disagreement with the
proposed consequences. The rank order of responses
was: decrease drug access opportunity (3.18), favor
users’ social reintegration (3.03), favor users’
treatment and recovery (3.00), ensure public safety
(2.97), benefit society (2.94), protect the drug user
(2.87), respect human rights (2.86), punish drug
dealers (2.54), punish drug user (2.47), and increase
criminal behavior (2.11). Respondents were asked
why drug users should be arrested. A higher score
indicates greater disagreement with the use of arrest
in particular situations. The rank order of responses
was: using illicit drugs (2.44), buying illicit drugs
(2.17), carrying small amounts of illicit drugs (1.99),
violent behavior (1.46), selling illicit drugs (1.31), and
trafficking illicit drugs (1.22). Respondents were asked
if various institutions respected the rights of people
with drug problems. A higher score indicated greater
disagreement. The health system had the lowest score
(2.21) and police the highest (2.59).
Respondents feeling stigmatized
Respondents were asked about feeling
stigmatized because of a family member’s or friend’s
drug problem. More than half of the respondents
indicated that they had experienced various types of
stigma due to drug use by a family member or friend.
Table 3 shows the percentages of people who
responded affirmatively to the corresponding
questions. Most of the situations are related with their
social relationships and the difficulties to communicate
issues regarding their familiars using illegal drugs.
Table 3 - Perceived stigma related situations - by
respondents’ due to family member or friend using
drugs
noitautisdetaleramgitS %
gurdlailimafgnissucsiderofebllewnosrepawonkottiaW
melborp %3.86
tercesaesugurdlailimafpeekotaedidoogasiknihT %4.05
rebmemylimafasahtcejbustahttcafehtedihsemitemoS
melborpgurdhtiw %4.54
rebmemylimaftuobaenoynallettonotdesivdaneebevaH
melborpgurdahtiw %2.04
eruoynonwodkoolthgimyehtesuacebelpoepdiovA
noitautislailimaf %3.13
tuobawenkyehtesuacebylriafnutcejbusdetaertelpoeP
noitautislailimaf %9.03
lailimaftuobatuodnuofyehtecnotcejbusdetcejersdneirF
noitautis %3.03
tuobatuodnuofyehtnehwtcejbusfodiarfaerewelpoeP
noitautislailimaf %7.62
lailimafer-tcejbusnopuevagsrebmemylimafemoS
noitautis %7.42
n=1008
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Help-seeking efforts
Overall 65.1% of respondents indicated that
the family member or friend who was using illicit drugs
needed treatment, and 40% stated that the person
had obtained treatment. Just over half (53.9%) were
involved in getting help for the person and 65.8%
tried to get specific treatment for the person. On the
difficulty of finding treatment for illicit drug users, the
merged score was 2.07, using a scale where 1 was
“not difficult” and the highest score of 4 was
“impossible”.
DISCUSSION
According to the literature, this is the first
multi-centric study to gather information and
describe il l icit drug users’ family and friends’
perspectives from seven Latin American countries
regarding protective and risk factors, preventive
initiatives, availability of services and existing
policies and laws pertaining to illicit drug use. Even
though it is not an objective of this study, it is
relevant to remark that there was little variation
across study sites in terms of the results.
Some key themes emerged from the results.
For example, respondents’ views reflect the reality
that there are many complex risk and protective
factors in different domains (individual, family, peer,
school and community/societal) and they interact
among each other. This assumption is in line with
recent scientific evidence regarding addictions(2-5). The
respondents chose psycho-social factors such as
curiosity, poor self-esteem, loneliness or seeking
pleasure to explain addictions, over genetic or
biological reasons.
With regard to the responsibi l i ty for
preventing illicit drug problems, the respondents
tended to attribute greater responsibility to families
and governments over religious institutions or
private companies. This may stem from their own
experiences with families and friend rather than
the lack of recognition of the need for a policy
response from the society. However, the
respondents had mixed opinions about the value
of national laws and policies. They generally were
more supportive of arrests for trafficking illicit
drugs, selling illicit drugs and violent behavior than
for using or buying illicit drugs. These perceptions
might be related with a variety of factors such as
the real weaknesses of laws and policies, issues
related with implementation and enforcement, and
or their own impressions of government or the
just ice system. This is a current area of
international debate(15-17) and Latin America needs
to achieve progress in identifying what works best
in this region.
However, when asked about access to
treatment facilities, the majority said that there were
not enough. The most common barriers for people
getting to treatment included shame about drug use,
cost and not enough treatment options. In terms of
services alternatives, church groups were mentioned
most often, followed by general hospital and health
care clinics. It is important to contrast these views
with the current existent addiction treatment services
in each location as well as the role that churches may
have in Latin America in treatment and recovery
support.
Finally, it is necessary to remark that most of
the respondents indicated that they had experienced
various types of stigma because of drug use by a
family member or friend. Those seeking or in
treatment for illegal drug issues are frequently and
disproportionately marginalized(18).
CONCLUSION
This novel cross-sectional multi-centre study
explored how family members and friends of illicit
drug users perceived protective and risk factors,
treatment facilities and policies and laws respecting
illicit drug use in Latin America. It provided a
meaningful perspective for better understanding of
the drug phenomenon in the region. It also highlighted
some health promotion and prevention based
alternatives for addressing the main challenges. The
indispensable role of families and friends in innovative
and culturally relevant strategic responses to the
challenges was made apparent. Future research is
needed in terms of this research subject for Latin
America.
STUDY LIMITATIONS
Among the limitations of this study are: (1)
The characteristics of the sample, considering the
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sampling method (e.g., no random selection) and size
does not allow to generalize the results at the country
or Regional levels neither to compare accurately the
results among countries. (2) The results presented
here are based on self-reports and are thus subject
to the various kinds of error associated with this
approach, including the possibility of social desirability
and recall biases. (3) Some potential weaknesses in
terms of the validity of the applied measurement
instrument (questionnaire).
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